Login
|
Register
News
Media
Insights
Peer Exchange
OncNurse TV
Webinars
Podcasts
Resources
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancers
Supportive Care
Blood Cancers
Prevention
Genetics
Nurse Navigation
Immuno-Oncology
Drug Safety
Skin Cancer/Melanoma
Brain Cancer
Childhood/AYA Cancer
Head and Neck Cancers
Adverse Event Management
Contributors
Conferences
Partners
Advocacy
Associations
Schools of Nursing
Publications
CE
Register now to learn about a new option for relapsed or refractory follicular lymphoma
Gynecologic Cancers
Sequencing Ovarian Cancer Treatments Remains Challenging
BY BRITTANY LOVELY
FDA Approves Niraparib for Maintenance Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
BY BRIELLE BENYON
Racial Disparities Exist in Endometrial Cancer Care
BY ELLIE LEICK
Pain, Stigma, and Other Gynecologic Cancer Issues
BY DON S. DIZON, MD, FACP
FDA Grants Dual Immunotherapy Regimen a Fast Track Designation for Cervical Cancer
BY JASON M. BRODERICK
FDA Approves Cytology Test to Improve Prevention of Cervical Cancer
BY JASON M. BRODERICK
FDA Accepts BLA for Bevacizumab Biosimilar
BY GINA COLUMBUS
FDA Accepts Niraparib Application for Frontline Maintenance Ovarian Cancer Treatment
BY JASON M. BRODERICK
PARP Inhibitor Becomes Standard of Care for Advanced Ovarian Cancer Subset
BY BRIELLE BENYON
FDA Grants Priority Review to Olaparib Plus Bevacizumab for Frontline Maintenance in Ovarian Cancer
BY GINA COLUMBUS
<< Prev Page
Next Page >>
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources
Newsroom
Continuing Education
Discussions
Web Exclusives
About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.